From Medscape Oncology

Coverage from the

American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting

September 25 - 28, 2016; Boston, Massachusetts

September 25 - 28, 2016 Boston, Massachusetts

ASTRO Prostate Cancer Radiation in 2.5 Weeks: 'Extreme' but Safe Scandinavian researchers are pushing the boundaries of hypofractionation in a phase 3 trial among men with intermediate-risk disease; 2-year toxicity data are now available.
Medscape Medical News, September 27, 2016
ASTRO Magic Mouthwash Really Works, Says Phase 3 Trial The mouth rinse is widely used but has not been robustly studied. That is now changed, and the news is good.
Medscape Medical News, September 27, 2016
ASTRO First Phase 3 Results for SRS vs WBRT for Brain Metastases There has been a lot of news coverage about stereotactic radiosurgery for brain metastases. But in a first-of-its-kind phase 3 trial comparing it with whole-brain radiotherapy, the results were mixed.
Medscape Medical News, September 26, 2016

Conference News

ASTRO Likely to Continue: A Lung Cancer Improved-Survival Trend
Medscape Medical News, October 6, 2016
ASTRO More Evidence: Shorter RT Safe in Low-Risk Prostate Cancer
Medscape Medical News, October 6, 2016
ASTRO Lymphedema and Breast Cancer: When Is Risk Greatest?
Medscape Medical News, October 5, 2016
ASTRO Good News: Racial Parity in a US Lung Cancer Trial
Medscape Medical News, October 5, 2016
ASTRO Death While on Radiation Therapy
Medscape Medical News, September 29, 2016
ASTRO Should DCIS Patients Get a Radiation Boost?
Medscape Medical News, September 29, 2016
ASTRO Brachytherapy Alone for Intermediate-Risk Prostate Cancer
Medscape Medical News, September 29, 2016
ASTRO 'Good Tool': Hydrogel Spares Rectum From Radiation
Medscape Medical News, September 28, 2016

ASTRO Is IMRT for Gynecologic Cancers Less Toxic?
Medscape Medical News, September 28, 2016
ASTRO Large Genome Analysis Identifies Three Prostate Cancer Subtypes
Medscape Medical News, September 27, 2016
ASTRO SBRT Doubled Survival Rates in Stage I NSCLC at VA
Medscape Medical News, September 27, 2016
ASTRO Prostate Cancer Radiation in 2.5 Weeks: 'Extreme' but Safe
Medscape Medical News, September 27, 2016
ASTRO Magic Mouthwash Really Works, Says Phase 3 Trial
Medscape Medical News, September 27, 2016
$Hypofractionated RT Halves Tx Time for Infirm NSCLC Patients$ ASTRO Hypofractionated RT Halves Tx Time for Infirm NSCLC Patients
Medscape Medical News, September 27, 2016
ASTRO SRS Beats Watching for Local Control of Brain Mets
Medscape Medical News, September 26, 2016
ASTRO First Phase 3 Results for SRS vs WBRT for Brain Metastases
Medscape Medical News, September 26, 2016

Popular News from ASTRO 2015

'No Brainer': IMRT for Locally Advanced NSCLC Intensity-modulated radiotherapy (IMRT) is associated with fewer adverse events than standard radiotherapy and should now be considered routinely, say researchers.
Medscape Medical News, Oct 23, 2015
Radiation in Children With Ependymoma Improves Outcomes The largest trial in this rare type of brain tumor has shown that radiotherapy after surgery improves outcomes compared with what has been seen historically.
Medscape Medical News, Oct 20, 2015
Green Light for Less Therapy for HPV Oropharyngeal Cancer Mounting evidence suggests that deintensification is feasible and that it reduces toxicity without compromising survival.
Medscape Medical News, Oct 19, 2015

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage